Introduction

CJC-1295 with DAC is a synthetic peptide designed as a growth hormone-releasing hormone (GHRH) analog. The DAC (Drug Affinity Complex) modification extends its half-life, making it highly valuable for research involving growth hormone release and metabolic regulation.

Researchers often study CJC-1295 with DAC alongside peptides like Ipamorelin and GHRP-6 to explore synergistic effects on growth hormone signaling and metabolic pathways.

Molecular Structure of CJC-1295 with DAC

CJC-1295 with DAC has the following characteristics:

• GHRH analog peptide
• Modified with DAC for extended half-life
• Stable under lyophilized conditions

Its structure allows researchers to study long-acting growth hormone release in laboratory experiments.

Function and Research Importance

CJC-1295 with DAC is primarily studied for:

• Stimulating pulsatile growth hormone release
• Supporting metabolic regulation
• Evaluating synergistic peptide effects

Its extended half-life makes it a preferred peptide for long-term studies in laboratory settings.

Handling and Storage

• Store in lyophilized form
• Keep refrigerated (2–8°C)
• Avoid repeated freeze-thaw cycles

Proper handling ensures reproducible experimental outcomes.

Conclusion

CJC-1295 with DAC is a valuable peptide in growth hormone research, offering stability and extended action for experimental studies.

FAQ

Q1: What is CJC-1295 with DAC peptide?
A: A GHRH analog peptide modified with DAC for extended half-life.

Q2: How does it function?
A: Stimulates long-lasting growth hormone release.

Q3: How should it be stored?
A: Lyophilized, refrigerated, and kept dry.